$STTK 4 SEC Filings

Filed On	Filing
07 Jul 2026	Form 4: Shukla Abhinav A., Chief Technical Officer Received 410 shares by exercise or conversion ($1.46K) · Sold 410 shares ($2.87K) · Received 12,153 shares by exercise or conversion ($43.4K)
02 Jul 2026	Form 4: Shukla Abhinav A., Chief Technical Officer Received 23,365 shares by exercise or conversion ($83.4K) · Sold 23,365 shares ($165K) · Received 100 shares by exercise or conversion ($357) · 1 more
02 Jul 2026	Form 4: Pandite Arundathy N., Chief Medical Officer Sold 30,000 shares ($210K)
15 Jun 2026	Form 4: Ashiya Mona, Director Acquired 1,250,000 Pre-Funded Warrants (right to buy) (Open Market Purchase)
15 Jun 2026	Form 4: Orbimed Advisors Llc, Director and 2 others Acquired 1,250,000 Pre-Funded Warrants (right to buy) (Open Market Purchase)
11 Jun 2026	Form 4: Siegall Clay B, Director Bought 62,500 shares ($250K)
09 Jun 2026	Form 4: Orbimed Advisors Llc, Director and 2 others Acquired 18,439,788 Pre-Funded Warrants (right to buy) (Derivative Conversion) · Converted 18,439,788 Common Warrants (right to buy)
09 Jun 2026	Form 4: Ashiya Mona, Director Acquired 18,439,788 Pre-Funded Warrants (right to buy) (Derivative Conversion) · Converted 18,439,788 Common Warrants (right to buy)
02 Jun 2026	Form 4: Baker Daniel G., Director Granted 81,000 Stock Option (Right to Buy)
02 Jun 2026	Form 4: Golumbeski George, Director Granted 81,000 Stock Option (Right to Buy)
02 Jun 2026	Form 4: Gibson Neil W, Director Granted 81,000 Stock Option (Right to Buy)
02 Jun 2026	Form 4: Ashiya Mona, Director Granted 81,000 Stock Option (Right to Buy)
02 Jun 2026	Form 4: Siegall Clay B, Director Granted 81,000 Stock Option (Right to Buy)
02 Jun 2026	Form 4: Boudreau Helen M, Director Granted 81,000 Stock Option (Right to Buy)
27 May 2026	Form 4: Siegall Clay B, Director Received 128,054 shares as a grant or award ($139K) · Exercised 128,054 Warrants (Right to Buy)
21 May 2026	Form 4: Shukla Abhinav A., Chief Technical Officer Received 5,122 shares as a grant or award ($5.56K) · Exercised 5,122 Warrants (Right to Buy)
18 May 2026	Form 4: Stout Stephen, See Remarks Received 12,805 shares as a grant or award ($13.9K) · Exercised 12,805 Warrants (Right to Buy)
14 May 2026	Form 4: Neill Andrew R, Chief Financial Officer Received 64,027 shares as a grant or award ($69.4K) · Exercised 64,027 Warrants (Right to Buy)
14 May 2026	Form 4: Shukla Abhinav A., Chief Technical Officer Received 2,032 shares by exercise or conversion ($7.25K) · Sold 2,032 shares ($14.2K)
14 May 2026	Form 4: Pandite Arundathy N., Chief Medical Officer Sold 30,000 shares ($198K)

Comments